P41181 (AQP2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 132.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Aquaporin-2 Short name=AQP-2 Alternative name(s): ADH water channel Aquaporin-CD Short name=AQP-CD Collecting duct water channel protein WCH-CD Water channel protein for renal collecting duct | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 271 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Forms a water-specific channel that provides the plasma membranes of renal collecting duct with high permeability to water, thereby permitting water to move in the direction of an osmotic gradient. |
| Subcellular location | Apical cell membrane; Multi-pass membrane protein. Basolateral cell membrane; Multi-pass membrane protein By similarity. Cytoplasmic vesicle membrane; Multi-pass membrane protein. Golgi apparatus › trans-Golgi network membrane; Multi-pass membrane protein. Note: Shuttles from vesicles to the apical membrane. Vasopressin-regulated phosphorylation is required for translocation to the apical cell membrane. PLEKHA8/FAPP2 is required to transport AQP2 from the TGN to sites where AQP2 is phosphorylated. Ref.7 |
| Tissue specificity | Expressed in renal collecting tubules. |
| Domain | Aquaporins contain two tandem repeats each containing three membrane-spanning domains and a pore-forming loop with the signature motif Asn-Pro-Ala (NPA). |
| Post-translational modification | Ser-256 phosphorylation is necessary and sufficient for expression at the apical membrane. Endocytosis is not phosphorylation-dependent. |
| Involvement in disease | Diabetes insipidus, nephrogenic, autosomal (ANDI) [MIM:125800]: A disorder caused by the inability of the renal collecting ducts to absorb water in response to arginine vasopressin. Characterized by excessive water drinking (polydypsia), excessive urine excretion (polyuria), persistent hypotonic urine, and hypokalemia. Inheritance can be autosomal dominant or recessive. |
| Sequence similarities | Belongs to the MIP/aquaporin (TC 1.A.8) family. [View classification] |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 271 | 271 | Aquaporin-2 | PRO_0000063934 | |||||
Regions | |||||||||
| Topological domain | 1 – 16 | 16 | Cytoplasmic Potential | ||||||
| Transmembrane | 17 – 34 | 18 | Helical; Potential | ||||||
| Topological domain | 35 – 40 | 6 | Extracellular Potential | ||||||
| Transmembrane | 41 – 59 | 19 | Helical; Potential | ||||||
| Topological domain | 60 – 85 | 26 | Cytoplasmic Potential | ||||||
| Transmembrane | 86 – 107 | 22 | Helical; Potential | ||||||
| Topological domain | 108 – 127 | 20 | Extracellular Potential | ||||||
| Transmembrane | 128 – 148 | 21 | Helical; Potential | ||||||
| Topological domain | 149 – 156 | 8 | Cytoplasmic Potential | ||||||
| Transmembrane | 157 – 176 | 20 | Helical; Potential | ||||||
| Topological domain | 177 – 202 | 26 | Extracellular Potential | ||||||
| Transmembrane | 203 – 224 | 22 | Helical; Potential | ||||||
| Topological domain | 225 – 271 | 47 | Cytoplasmic Potential | ||||||
| Motif | 68 – 70 | 3 | NPA 1 | ||||||
| Motif | 184 – 186 | 3 | NPA 2 | ||||||
Amino acid modifications | |||||||||
| Modified residue | 256 | 1 | Phosphoserine; by PKA Ref.7 | ||||||
| Modified residue | 261 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 264 | 1 | Phosphoserine By similarity | ||||||
| Glycosylation | 123 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Natural variant | 22 | 1 | L → V in ANDI. Ref.9 | VAR_015239 | |||||
| Natural variant | 28 | 1 | L → P in ANDI. Ref.15 | VAR_015240 | |||||
| Natural variant | 47 | 1 | A → V in ANDI. Ref.15 | VAR_015241 | |||||
| Natural variant | 57 | 1 | Q → P in ANDI. Ref.16 Corresponds to variant rs28931580 [ dbSNP | Ensembl ]. | VAR_015256 | |||||
| Natural variant | 64 | 1 | G → R in ANDI. Ref.3 | VAR_004401 | |||||
| Natural variant | 68 | 1 | N → S in ANDI. Ref.10 | VAR_015242 | |||||
| Natural variant | 70 | 1 | A → D in ANDI. Ref.19 | VAR_062585 | |||||
| Natural variant | 71 | 1 | V → M in ANDI. Ref.15 | VAR_015243 | |||||
| Natural variant | 100 | 1 | G → R in ANDI. Ref.20 | VAR_062586 | |||||
| Natural variant | 100 | 1 | G → V in ANDI. Ref.16 Corresponds to variant rs28929477 [ dbSNP | Ensembl ]. | VAR_015257 | |||||
| Natural variant | 121 | 1 | L → F. Corresponds to variant rs11169226 [ dbSNP | Ensembl ]. | VAR_037577 | |||||
| Natural variant | 125 | 1 | T → M in ANDI. Ref.12 Ref.14 Ref.15 | VAR_015244 | |||||
| Natural variant | 126 | 1 | T → M in ANDI. Ref.10 | VAR_015245 | |||||
| Natural variant | 147 | 1 | A → T in ANDI. Ref.10 | VAR_015246 | |||||
| Natural variant | 168 | 1 | V → M in ANDI. Ref.11 | VAR_015247 | |||||
| Natural variant | 175 | 1 | G → R in ANDI. Ref.12 Ref.14 Ref.15 | VAR_015248 | |||||
| Natural variant | 180 | 1 | G → S in ANDI. Ref.20 | VAR_062587 | |||||
| Natural variant | 181 | 1 | C → W in ANDI. Ref.9 | VAR_015249 | |||||
| Natural variant | 185 | 1 | P → A in ANDI. Ref.15 | VAR_015250 | |||||
| Natural variant | 187 | 1 | R → C in ANDI; mutant protein does not fold properly and is not functional. Ref.3 Ref.17 | VAR_004402 | |||||
| Natural variant | 187 | 1 | R → H in ANDI. Ref.19 | VAR_062588 | |||||
| Natural variant | 190 | 1 | A → T in ANDI; mutant protein does not fold properly and is not functional. Ref.12 Ref.17 | VAR_015251 | |||||
| Natural variant | 194 | 1 | V → I. Ref.15 | VAR_015252 | |||||
| Natural variant | 202 | 1 | W → C in ANDI. Ref.8 | VAR_015253 | |||||
| Natural variant | 216 | 1 | S → P in ANDI. Ref.3 Ref.11 | VAR_004403 | |||||
| Natural variant | 254 | 1 | R → L in ANDI; results in the loss of arginine vasopressin-mediated phosphorylation at S-256. Ref.18 | VAR_062589 | |||||
| Natural variant | 254 | 1 | R → Q in ANDI; exerts a dominant-negative effect on wild-type-AQP2 in that it interferes with its trafficking to the apical membrane; is a loss of function instead of a gain of function mutation on dominant nephrogenic diabetes insipidus. Ref.21 | VAR_062590 | |||||
| Natural variant | 258 | 1 | E → K in ANDI; retained in the Golgi compartment. Ref.13 Ref.22 | VAR_015254 | |||||
| Natural variant | 262 | 1 | P → L in ANDI; mutant protein folds properly and is functional but is retained in intracellular vesicles and does not localize to the ER; upon coexpression with wild-type AQP2 mutant protein interacts with wild-type AQP2 and the resulting heterotetramer properly localizes to the apical membrane. Ref.12 Ref.17 | VAR_015255 | |||||
Experimental info | |||||||||
| Mutagenesis | 148 | 1 | S → A: No effect on sorting from the ER to the vesicles, redistribution to apical membrane, or endocytosis. Ref.7 | ||||||
| Mutagenesis | 148 | 1 | S → D: Retained in the endoplasmic reticulum. Ref.7 | ||||||
| Mutagenesis | 229 | 1 | S → A: No effect on sorting from the ER to the vesicles, redistribution to apical membrane, or endocytosis. Ref.7 | ||||||
| Mutagenesis | 229 | 1 | S → D: No effect on sorting from the ER to the vesicles, redistribution to apical membrane, or endocytosis. Ref.7 | ||||||
| Mutagenesis | 231 | 1 | S → A: No effect on sorting from the ER to the vesicles, redistribution to apical membrane, or endocytosis. Ref.7 | ||||||
| Mutagenesis | 231 | 1 | S → D: No effect on sorting from the ER to the vesicles, redistribution to apical membrane, or endocytosis. Ref.7 | ||||||
| Mutagenesis | 244 | 1 | T → A: No effect on sorting from the ER to the vesicles, redistribution to apical membrane, or endocytosis. Ref.7 | ||||||
| Mutagenesis | 244 | 1 | T → E: No effect on sorting from the ER to the vesicles, redistribution to apical membrane, or endocytosis. Ref.7 | ||||||
| Mutagenesis | 256 | 1 | S → A: Retained in vesicles. Ref.7 | ||||||
| Mutagenesis | 256 | 1 | S → D: Expressed in the apical membrane. Ref.7 | ||||||
| Sequence conflict | 35 – 38 | 4 | PQAL → ATAP Ref.4 | ||||||
| Sequence conflict | 83 | 1 | V → F Ref.4 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine." Deen P.M.T., Verdijk M.A.J., Knoers V.V.A.M., Wieringa B., Monnens L.A.H., van Os C.H., van Oost B.A. Science 264:92-94(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | "Isolation of human aquaporin-CD gene." Uchida S., Sasaki S., Fushimi K., Marumo F. J. Biol. Chem. 269:23451-23455(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene." van Lieburg A.F., Verdijk M.A.J., Knoers V.V.A.M., van Essen A.J., Proesmans W., Mallmann R., Monnens L.A.H., van Oost B.A., van Os C.H., Deen P.M.T. Am. J. Hum. Genet. 55:648-652(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS ANDI ARG-64; CYS-187 AND PRO-216. |
| [4] | "Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct." Sasaki S., Fushimi K., Saito H., Saito F., Uchida S., Ishibashi K., Kuwahara M., Ikeuchi T., Inui K., Nakajima K. J. Clin. Invest. 93:1250-1256(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. Tissue: Kidney. |
| [5] | "Heteroligomerization of an aquaporin-2 mutant with wild-type aquaporin-2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidus." Marr N., Bichet D.G., Lonergan M., Arthus M.-F., Jeck N., Seyberth H.W., Rosenthal W., van Os C.H., Oksche A., Deen P.M.T. Hum. Mol. Genet. 11:779-789(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. Tissue: Kidney. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Colon. |
| [7] | "The role of putative phosphorylation sites in the targeting and shuttling of the aquaporin-2 water channel." van Balkom B.W.M., Savelkoul P.J.M., Markovich D., Hofman E., Nielsen S., van der Sluijs P., Deen P.M.T. J. Biol. Chem. 277:41473-41479(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-256, MUTAGENESIS OF SER-148; SER-229; SER-231; THR-244 AND SER-256. |
| [8] | "Two novel mutations in the aquaporin-2 and the vasopressin V2 receptor genes in patients with congenital nephrogenic diabetes insipidus." Oksche A., Moeller A., Dickson J., Rosendahl W., Rascher W., Bichet D.G., Rosenthal W. Hum. Genet. 98:587-589(1996) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ANDI CYS-202. |
| [9] | "Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response." Canfield M.C., Tamarappoo B.K., Moses A.M., Verkman A.S., Holtzman E.J. Hum. Mol. Genet. 6:1865-1871(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ANDI VAL-22 AND TRP-181. |
| [10] | "New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels." Mulders S.M., Knoers N.V., Van Lieburg A.F., Monnens L.A., Leumann E., Wuhl E., Schober E., Rijss J.P.L., Van Os C.H., Deen P.M.T. J. Am. Soc. Nephrol. 8:242-248(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ANDI SER-68; MET-126 AND THR-147. |
| [11] | "Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus." Vargas-Poussou R., Forestier L., Dautzenberg M.D., Niaudet P., Dechaux M., Antignac C. J. Am. Soc. Nephrol. 8:1855-1862(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ANDI MET-168 AND PRO-216. |
| [12] | "Aquaporin-2, a vasopressin-sensitive water channel, and nephrogenic diabetes insipidus." Kuwahara M. Intern. Med. 37:215-217(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ANDI MET-125; ARG-175; THR-190 AND LEU-262. |
| [13] | "An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex." Mulders S.M., Bichet D.G., Rijss J.P.L., Kamsteeg E.-J., Arthus M.-F., Lonergan M., Fujiwara M., Morgan K., Leijendekker R., van der Sluijs P., van Os C.H., Deen P.M.T. J. Clin. Invest. 102:57-66(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ANDI LYS-258. |
| [14] | "Novel mutations in aquaporin-2 gene in female siblings with nephrogenic diabetes insipidus: evidence of disrupted water channel function." Goji K., Kuwahara M., Gu Y., Matsuo M., Marumo F., Sasaki S. J. Clin. Endocrinol. Metab. 83:3205-3209(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ANDI MET-125 AND ARG-175. |
| [15] | "Cell-biologic and functional analyses of five new Aquaporin-2 missense mutations that cause recessive nephrogenic diabetes insipidus." Marr N., Bichet D.G., Hoefs S., Savelkoul P.J.M., Konings I.B., De Mattia F., Graat M.P., Arthus M.-F., Lonergan M., Fujiwara T.M., Knoers N.V., Landau D., Balfe W.J., Oksche A., Rosenthal W., Muller D., Van Os C.H., Deen P.M. J. Am. Soc. Nephrol. 13:2267-2277(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ANDI PRO-28; VAL-47; MET-71; MET-125; ARG-175 AND ALA-185, VARIANT ILE-194. |
| [16] | "Two novel aquaporin-2 mutations responsible for congenital nephrogenic diabetes insipidus in Chinese families." Lin S.H., Bichet D.G., Sasaki S., Kuwahara M., Arthus M.-F., Lonergan M., Lin Y.-F. J. Clin. Endocrinol. Metab. 87:2694-2700(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ANDI PRO-57 AND VAL-100. |
| [17] | "A novel mechanism in recessive nephrogenic diabetes insipidus: wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L." de Mattia F., Savelkoul P.J.M., Bichet D.G., Kamsteeg E.-J., Konings I.B.M., Marr N., Arthus M.-F., Lonergan M., van Os C.H., van der Sluijs P., Robertson G., Deen P.M.T. Hum. Mol. Genet. 13:3045-3056(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ANDI CYS-187; THR-190 AND LEU-262, CHARACTERIZATION OF VARIANTS ANDI CYS-187; THR-190 AND LEU-262. |
| [18] | "Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus." de Mattia F., Savelkoul P.J.M., Kamsteeg E.-J., Konings I.B.M., van der Sluijs P., Mallmann R., Oksche A., Deen P.M.T. J. Am. Soc. Nephrol. 16:2872-2880(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ANDI LEU-254, CHARACTERIZATION OF VARIANT ANDI LEU-254. |
| [19] | "Two novel mutations in the aquaporin 2 gene in a girl with congenital nephrogenic diabetes insipidus." Cheong H.I., Cho S.J., Zheng S.H., Cho H.Y., Ha I.S., Choi Y. J. Korean Med. Sci. 20:1076-1078(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ANDI ASP-70 AND HIS-187. |
| [20] | "Novel mutations underlying nephrogenic diabetes insipidus in Arab families." Carroll P., Al-Mojalli H., Al-Abbad A., Al-Hassoun I., Al-Hamed M., Al-Amr R., Butt A.I., Meyer B.F. Genet. Med. 8:443-447(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ANDI ARG-100 AND SER-180. |
| [21] | "p.R254Q mutation in the aquaporin-2 water channel causing dominant nephrogenic diabetes insipidus is due to a lack of arginine vasopressin-induced phosphorylation." Savelkoul P.J.M., De Mattia F., Li Y., Kamsteeg E.-J., Konings I.B.M., van der Sluijs P., Deen P.M.T. Hum. Mutat. 30:E891-E903(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ANDI GLN-254, CHARACTERIZATION OF VARIANT ANDI GLN-254. |
| [22] | "Repulsion between Lys258 and upstream arginines explains the missorting of the AQP2 mutant p.Glu258Lys in nephrogenic diabetes insipidus." Kamsteeg E.-J., Stoffels M., Tamma G., Konings I.B.M., Deen P.M.T. Hum. Mutat. 30:1387-1396(2009) [PubMed] [Europe PMC] [Abstract] Cited for: MISSORTING MOTIF OF VARIANT ANDI LYS-258. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | Z29491 Genomic DNA. Translation: CAA82627.1. D31846 Genomic DNA. Translation: BAA06632.1. S73196 mRNA. Translation: AAB31999.1. S73197 mRNA. Translation: AAB31998.1. AF147093, AF147092 Genomic DNA. Translation: AAD38692.1. BC042496 mRNA. Translation: AAH42496.1. |
| IPI | IPI00012818. |
| PIR | A53442. I64818. |
| RefSeq | NP_000477.1. NM_000486.5. |
| UniGene | Hs.130730. |
3D structure databases | |
| ProteinModelPortal | P41181. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000199280. |
Protein family/group databases | |
| TCDB | 1.A.8.8.8. major intrinsic protein (MIP) family. |
PTM databases | |
| PhosphoSite | P41181. |
Polymorphism databases | |
| DMDM | 728874. |
Proteomic databases | |
| PaxDb | P41181. |
| PRIDE | P41181. |
Protocols and materials databases | |
| DNASU | 359. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000199280; ENSP00000199280; ENSG00000167580. |
| GeneID | 359. |
| KEGG | hsa:359. |
| UCSC | uc001rvn.3. human. |
Organism-specific databases | |
| CTD | 359. |
| GeneCards | GC12P050400. |
| HGNC | HGNC:634. AQP2. |
| HPA | CAB009866. |
| MIM | 107777. gene. 125800. phenotype. |
| neXtProt | NX_P41181. |
| Orphanet | 223. Nephrogenic diabetes insipidus. |
| PharmGKB | PA24920. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0580. |
| HOGENOM | HOG000288286. |
| HOVERGEN | HBG000312. |
| InParanoid | P41181. |
| KO | K09865. |
| OMA | ADWEERE. |
| OrthoDB | EOG4FJ89M. |
| PhylomeDB | P41181. |
Enzyme and pathway databases | |
| Reactome | REACT_15518. Transmembrane transport of small molecules. |
Gene expression databases | |
| ArrayExpress | P41181. |
| Bgee | P41181. |
| CleanEx | HS_AQP2. |
| Genevestigator | P41181. |
| GermOnline | ENSG00000167580. Homo sapiens. |
Family and domain databases | |
| Gene3D | 1.20.1080.10. 1 hit. |
| InterPro | IPR023271. Aquaporin-like. IPR000425. MIP. IPR022357. MIP_CS. [Graphical view] |
| PANTHER | PTHR19139. PTHR19139. 1 hit. |
| Pfam | PF00230. MIP. 1 hit. [Graphical view] |
| PRINTS | PR00783. MINTRINSICP. |
| SUPFAM | SSF81338. MIP. 1 hit. |
| TIGRFAMs | TIGR00861. MIP. 1 hit. |
| PROSITE | PS00221. MIP. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 359. |
| NextBio | 1501. |
| SOURCE | Search... |
Entry information
| Entry name | AQP2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P41181 Secondary accession number(s): Q9UD68 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
